Christopher Gibson - Aug 11, 2025 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Chief Executive Officer, Director
Signature
/s/ Kyle Nelson, attorney-in-fact
Stock symbol
RXRX
Transactions as of
Aug 11, 2025
Transactions value $
-$3,263,964
Form type
4
Date filed
8/13/2025, 09:03 PM
Previous filing
May 19, 2025
Next filing
Aug 19, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Gibson Christopher Chief Executive Officer, Director C/O RECURSION PHARMACEUTICALS, 41 S. RIO GRANDE STREET, SALT LAKE CITY /s/ Kyle Nelson, attorney-in-fact 2025-08-11 0001856369

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Conversion of derivative security $0 +424K +39.18% $0.00 1.5M Aug 11, 2025 Direct F1, F2
transaction RXRX Class A Common Stock Sale -$2.64M -500K -33.24% $5.28 1M Aug 11, 2025 Direct F2
transaction RXRX Class A Common Stock Gift $0 -10K -1% $0.00 995K Aug 11, 2025 Direct F2, F3
transaction RXRX Class A Common Stock Conversion of derivative security $0 +100K $0.00 100K Aug 11, 2025 by LAHWRAN-3 LLC F1, F2, F4
transaction RXRX Class A Common Stock Sale -$528K -100K -100% $5.28 0 Aug 11, 2025 by LAHWRAN-3 LLC F2, F4
transaction RXRX Class A Common Stock Conversion of derivative security $0 +17.9K $0.00 17.9K Aug 11, 2025 by Gibson Family Trust F1, F2, F5
transaction RXRX Class A Common Stock Sale -$94.4K -17.9K -100% $5.28 0 Aug 11, 2025 by Gibson Family Trust F2, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RXRX Class B Common Stock Conversion of derivative security $0 -424K -7.18% $0.00 5.47M Aug 11, 2025 Class A Common Stock 424K $0.00 Direct F1, F2, F6
transaction RXRX Class B Common Stock Conversion of derivative security $0 -100K -20.58% $0.00 386K Aug 11, 2025 Class A Common Stock 100K $0.00 by LAHWRAN-3 LLC F1, F2, F4, F6
transaction RXRX Class B Common Stock Conversion of derivative security $0 -17.9K -26.34% $0.00 50K Aug 11, 2025 Class A Common Stock 17.9K $0.00 by Gibson Family Trust F1, F2, F5, F6
holding RXRX Class B Common Stock 388K Aug 11, 2025 Class A Common Stock 0 $0.00 by LAHWRAN-4 LLC F6, F7
holding RXRX Stock Option (Right to Buy) 1.05M Aug 11, 2025 Class A Common Stock 0 $7.25 Direct F8
holding RXRX Stock Option (Right to Buy) 667K Aug 11, 2025 Class A Common Stock 0 $10.09 Direct F9
holding RXRX Stock Option (Right to Buy) 814K Aug 11, 2025 Class A Common Stock 0 $8.55 Direct F10
holding RXRX Stock Option (Right to Buy) 399K Aug 11, 2025 Class A Common Stock 0 $11.40 Direct F11
holding RXRX Stock Option (Right to Buy) 5.44K Aug 11, 2025 Class A Common Stock 0 $11.40 Direct
holding RXRX Stock Option (Right to Buy) 283K Aug 11, 2025 Class A Common Stock 0 $2.48 Direct F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents the automatic conversion of Class B Common Stock into Class A Common Stock.
F2 This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025.
F3 Represents the automatic conversion of Class B Common Stock into Class A Common Stock in connection with a bona-fide gift of shares by the Reporting Person
F4 The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.
F5 The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.
F6 Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
F7 The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.
F8 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F9 The option vests as to one forty-eighth (1/48th) of the original 666,898 shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F10 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F11 The option, originally for 416,350 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F12 The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.